Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OXA β-lactamases are a family of class D serine-based enzymes, conventionally named for their oxacillinase activity, that hydrolyze and inactivate β-lactam antibiotics such as penicillins, cephalosporins, and carbapenems. They are widely distributed among Gram-negative bacteria, often encoded by transferable plasmids as well as chromosomes, notably in ESKAPE pathogens. These enzymes are poorly inhibited by many standard β-lactamase inhibitors, with over 750 known variants conferring potentially both narrow- and extended-spectrum resistance. Some lipidated OXA β-lactamases, particularly in Acinetobacter spp., localize to the membrane and play significant roles in high-level antibiotic resistance. Their substrate specificity and catalytic mechanisms are structurally distinguished by a conserved Ser-x-x-Lys motif and a carboxylated lysine in the active site, making them challenging therapeutic targets in multidrug-resistant infections[1][2][3][4][5]. If specificity for a single variant is needed (e.g., OXA-23), more detailed names and function can be given, but "OXA β-lactamase" covers the therapeutically relevant class D β-lactamase enzymes responsible for much of current β-lactam resistance.
Drug hydrolysis (breaking the β-lactam ring, rendering antibiotics inactive); Confers resistance by enzymatically inactivating β-lactam antibiotics[3][4]
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Class D β-lactamase (OXA-type) (OXA β-lactamase).